Apogee Therapeutics, Inc. (NASDAQ: APGE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT APOGEE THERAPEUTICS, INC.

Apogee Therapeutics, Inc. (NASDAQ: APGE)
Listen to this Section


$86.46
-4.4400 ( -4.88% ) 645.6K

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Market Data


Open $86.46
Previous Close $90.90
Volume 645.6K
Market Cap $6.85B
Day Range $85.79 - $91.80
52 Week Range $34.34 - $95.32
Shares Outstanding 75.39M
Change % -4.88%
Net Change ▼ -4.4400
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2023
CountryUnited States
UnderwriterJefferies, TD Cowen, Stifel, Guggenheim Securities, Wedbush Securities, more

Insider Ownership Transactions

Total Amount Purchased: 365,853.00

Date Type Amount Purchased Purchaser
2025-10-15 Buy 365853.00 Shah Nimish P

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Aug 11, 2025
4 Insider transactions 1 Aug 08, 2025
8-k 8K-related 45 Jul 07, 2025
4 Insider transactions 1 Jul 03, 2025
8-k 8K-related 10 Jun 23, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025

Latest News


× Before browsing our site, please accept our cookies policy